CAMZYOS
CAMZYOS
Approved
DIN Number
02532557
Drug Class
Human
Market Date
Jan 9, 2023
Company
HC
bristol-myers squibb canada
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02532557
AIG Number0164242002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C01EB24 MAVACAMTEN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification24:04.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
MAVACAMTENActive
Strength: 5 MG
Monograph: MAVACAMTEN